HomeNews & TopicsResearchDrug overdose more likely in patients who leave hospital against medical advice

Drug overdose more likely in patients who leave hospital against medical advice

Published on

People who initiate a premature or “before medically advised” (BMA) hospital discharge have a 10-fold increase in the risk of drug overdose in the following month, according to new research in CMAJ (Canadian Medical Association Journal).

Patients leave hospital prematurely for a range of reasons, including improperly treated pain, cravings, stress that accentuates psychiatric issues, conflicts with hospital staff, and restrictions on movement or visitors. Hospital patients who initiate a BMA discharge are up to three times more likely to die in the following year than people who undergo routine physician-advised discharge. “Before medically advised” discharge has also been called “patient-initiated” or “against medical advice” discharge.

“For a long time, front-line doctors and nurses have wondered if BMA discharge increases subsequent overdose risk,” says Dr. John Staples, study senior author and a clinical associate professor at the University of British Columbia in Vancouver, BC. “For patients with substance use disorder, a long hospital stay can sometimes be a period of drug abstinence, potentially reducing opioid tolerance and interrupting access to [addiction] treatments. After these patients leave hospital, persistent pain and untreated addiction might prompt heavier-than-usual drug use. All these factors can increase the risk of subsequent overdose.”

To understand the link between BMA discharge and drug overdose, researchers conducted a study that examined health data on 189 808 hospital admissions occurring between 2015 and 2019 in British Columbia, Canada. A total of 6440 (3.4%) of these admissions ended with patients leaving hospital against medical advice. They found that patients with a BMA discharge were more likely to be younger males with psychiatric illness, substance use disorder, or a history of illicit drug use. The rate of fatal or nonfatal illicit drug overdose in the first 30 days after departure from hospital was 10 times higher after BMA discharge than after physician-advised discharge. “Before medically advised” discharge was associated with subsequent overdose even after accounting for other risk factors for overdose.

“These findings indicate that patients initiating a BMA discharge are at high risk of overdose, that BMA discharge may be a causal contributor to subsequent overdose, and that patients initiating a BMA discharge (especially those with a history of substance use disorder) should be offered urgent clinical and social supports to reduce overdose-related harms,” write the authors.

They suggest there are opportunities to improve medical care for these patients.

“Hospitals and health systems should develop evidence-based protocols to prevent BMA discharge and should explore novel means of postdeparture outreach to reduce the risk of drug overdose after hospital discharge,” the authors advise.

“‘Before medically advised’ departure from hospital and subsequent drug overdose: a population-based cohort study” was published September 23, 2024.

Latest articles

New research links brain region to linguistic ability

The cerebellum, typically associated with movement, may also play a key role in reading...

Making Clinical Research a Care Option: How Digital Infrastructure is Expanding Access to Clinical Trials in Canada

Across Canada, there is growing recognition that clinical research should not be viewed as...

Privacy-First AI: How Federated Learning Is Transforming Canadian Cancer Research

Imagine training an AI model on patient data from hospitals in Vancouver, Toronto, and...

People living with Parkinson’s face long wait times, inconsistent care across Canada

Parkinson Canada launches Limitless Parkinson’s Care campaign for this Parkinson’s Awareness Month. Accessing Parkinson’s care...

More like this

Only 4 days left to nominate your Nursing Hero

2026 – Celebrating Canada’s Nurses and Their Contributions! Along with having their story published, Hospital...

This Canadian startup is decoding the health data revealed in our eyes

If you’ve had a fluorescein angiography (FA), chances are you remember it. The procedure...

A new home for Canada’s largest Cancer Research Tumour Bank

Decades of cancer research — and thousands of patient tumour samples — now have...

Equity-focused study on immigrant kidney disease risk

HN Summary • A new SHN-led study published in BMJ Open reveals significant disparities in...

Shorter duration of antimicrobial therapy in common infections

HN Summary • Growing evidence shows that shorter courses of antibiotics are just as effective...

Global clinical trial exploring potential treatment for sickle cell disease

HN Summary • SHN is leading a global clinical trial testing tebapivat, an investigational oral...